Profound Medical Corp Stock Toronto S.E.
Stocks
PRN
CA74319B1067
Advanced Medical Equipment & Technology
|
End-of-day quote
Toronto S.E.
|
||
| - CAD | - |
|
| 08-07 | Profound Medical Corp., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Profound Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 355M 255M 221M 207M 189M 24.31B 361M 2.44B 951M 12.17B 956M 936M 40.59B | P/E 2026 * |
-8.11x | P/E 2027 * | -11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 355M 255M 221M 207M 189M 24.31B 361M 2.44B 951M 12.17B 956M 936M 40.59B | EV / Sales 2026 * |
9.81x | EV / Sales 2027 * | 5.97x |
| Free-Float |
95.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Profound Medical Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 71 | 2016-08-14 |
Mathieu Burtnyk
PSD | President | 44 | 2024-11-06 |
Rashed Dewan
DFI | Director of Finance/CFO | 58 | 2022-03-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Arun Menawat
CHM | Chairman | 71 | - |
Brian Ellacott
BRD | Director/Board Member | 68 | 2018-06-13 |
Arthur Rosenthal
BRD | Director/Board Member | 79 | 2018-06-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.14% | +2.95% | +23.17% | +10.51% | 223B | ||
| -0.96% | +1.85% | -2.62% | -20.81% | 145B | ||
| -0.39% | +6.98% | -17.11% | +31.05% | 142B | ||
| -0.09% | +4.19% | -49.89% | +0.07% | 74.52B | ||
| -0.64% | +3.54% | +19.05% | +14.84% | 53.63B | ||
| +0.03% | -0.15% | -16.01% | -17.13% | 50.14B | ||
| +0.29% | +5.07% | +23.45% | +17.25% | 41.87B | ||
| -0.06% | +4.06% | +40.12% | +44.23% | 40.89B | ||
| +1.28% | +4.08% | -2.85% | +1.92% | 32.65B | ||
| Average | -0.18% | +4.23% | +1.92% | +9.10% | 89.23B | |
| Weighted average by Cap. | -0.55% | +4.56% | +1.73% | +7.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.22M 25.98M 22.52M 21.11M 19.25M 2.48B 36.8M 249M 97.03M 1.24B 97.53M 95.42M 4.14B | 59.46M 42.65M 36.97M 34.65M 31.6M 4.07B 60.41M 408M 159M 2.04B 160M 157M 6.8B |
| Net income | -44.08M -31.62M -27.41M -25.69M -23.43M -3.02B -44.78M -303M -118M -1.51B -119M -116M -5.04B | -31.27M -22.43M -19.44M -18.22M -16.62M -2.14B -31.77M -215M -83.77M -1.07B -84.2M -82.37M -3.57B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PRN Stock
- PRN Stock
Select your edition
All financial news and data tailored to specific country editions

















